Emma Ramsay

T1/T2 Research Fellow
  • T1/T2 Working Group
  • Central Office Team


Doctor Emma Ramsay is a cancer biologist and Sydney Catalyst's T1 T2 Research Fellow. She completed her PhD in the laboratory of Professor Philip Hogg at the University of New South Wales, where she demonstrated the ability to utilise a tumour enzyme to deliver a prodrug to the tumour mass. In 2012 she received the Pfizer Studentship Award at the NSW Premier's Award for Outstanding Cancer Research and subsequently spent six months at Pfizer's La Jolla site in the Cancer Metabolism research team. On completion of her PhD she joined Professor Craig Logsdon's group at The University of Texas MD Anderson Center, where she worked on a number of early stage translational projects in pancreatic cancer.

In 2015 she returned to Australia and began working at The University of Sydney. She works with blood from Sydney Catalyst's EnRICH program, studying thrombotic events in lung cancer patients by measuring procoagulant platelets.


Research Interests:   

Emma's interest lies in T1 T2 translational cancer research- identifying novel targets and biomarkers and developing ways to utilise this knowledge in clinical practice. As the T1 T2 research fellow, she is particularly interested in collaborating with Catalyst members who have novel biomarkers and assays that can be utilised within the EnRICH program.

She has published ten original research articles, three review articles and one book chapter spanning her eleven year career in research including papers published in the Journal for ImmunoTherapy of Cancer, British Journal of Pharmacology and Molecular Pharmaceutics.